3.1. Evidence from Clinical Trials on GLP-1 RAs and Tirzepatide in Obesity: Effects on Weight Reduction and the Amelioration of Obesity-Related Organ Damage. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.